Genome-integrating stem cell reprogramming introduces pluripotency factors via retroviral or lentiviral vectors, enabling stable iPSC generation. While efficient, this method carries risks of insertional mutagenesis, making it suitable for mechanistic studies and non-clinical applications in disease modeling and developmental biology.
